Corneal Surface Disorders
Glaukos Corp. focuses on clinical research in persistent corneal epithelial defects, with attention to therapies intended to support corneal re-epithelialization and restore the integrity of the ocular surface.
- Persistent corneal epithelial defects
- Corneal epithelial healing
- Ocular surface repair
Its research activity is centered on ophthalmic treatment development for conditions where the cornea fails to heal normally, reflecting a narrow therapeutic emphasis within eye disease.
Ophthalmic Therapeutics
The sponsor’s clinical portfolio includes investigation of ophthalmic gel therapy for localized treatment of the corneal epithelium, highlighting interest in topical approaches for anterior segment disease.
- Topical ophthalmic therapy
- Anterior segment disease
- Corneal protection
This area reflects a therapeutic focus on eye-surface medication designed for direct application to damaged corneal tissue.
Corneal Imaging and Assessment
Clinical evaluation in the sponsor’s research includes fluorescein staining of the cornea and digital image review, indicating an interest in objective assessment of corneal healing and epithelial integrity.
- Fluorescein corneal staining
- Digital ocular imaging
- Central reading center
These assessment methods support precise monitoring of corneal wound closure and surface recovery in ophthalmology studies.
Ocular Tissue Repair
Glaukos Corp. is involved in research addressing tissue repair in the eye, with particular relevance to conditions requiring sustained restoration of the corneal surface over time.
- Ocular tissue regeneration
- Corneal wound healing
- Surface epithelial restoration
The therapeutic interest lies in interventions for patients with chronic corneal epithelial injury and incomplete healing of the ocular surface.
